CCG has the expertise to combine whole group protocol studies with small intra-group investigations of tumor biology. Large scale clinical programs are needed to consolidate data accrual of the past decade. Included in small group studies are those utilizing data on experiments in nature, i.e., adenosine deaminase (ADA) deficiency; anti-cancer effects of interferon; anti-tumor antibodies (common ALL, neuroblastoma); transplantation (allogeneic, autologous) biology; autologous lymphocyte therapy; radiosensitizer therapy; limb salvaging techniques/aggressive metastatic surgical attack; and diagnostic imaging procedures. Induced ADA deficiency can be applied to the study of T-cell leukemia and to the nature of lymphoblast modulation. Interferon data can be applied to the study of non-T ALL, non-Hodgkin's lymphoma and osteosarcoma and to the nature of tumor cell death. Anti-(common) ALL antibody studies can be applied to the development of common ALL and non-T, non-B lymphoma protocols. Specific anti-neuroblastoma antibody data can be applied to the development of randomized studies comparing chemotherapy and chemotherapy plus adjuvant antibody therapy. Allogenic transplantation for AML can be expanded to relapsing high risk ALL and high risk lymphoma. Autologous marrow transplantation rescue is applicable for megadose therapy studies of leukemia, lymphoma and a variety of solid tumors and as a means of evaluating techniques for identifying occult tumor burdens. Similarly, autologous lymphocyte infusion into brain tumors can test the hypothesis that such malignancies occupy immunologically priviledged sites and in turn be incorporated into a randomized radiosensitizer therapy study. Conflicting osteosarcoma data can be resolved by comparing pre-op megadose therapy to surgery alone (including evaluation of transfer factor, limb salvaging, and evaluation of the time/therapy sequence in treatment of metastatic disease). Extensive investigation of new agents is required in high risk Wilms' and Ewing's sarcoma and rhabdomyosarcoma. Efficacy studies of appropriate imaging techniques are mandated in virtually all protocols in which tumor delineation is essential. And in all studies active participation by nurse specialists should be encouraged in order to enhance protocol development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA020320-10
Application #
3556503
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1978-08-01
Project End
1988-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
10
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Cooper, R; Khakoo, Y; Matthay, K K et al. (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol 36:623-9
Kammen, B F; Matthay, K K; Pacharn, P et al. (2001) Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol 176:755-9
Sposto, R; Meadows, A T; Chilcote, R R et al. (2001) Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol 37:432-41
Fernandez, M C; Krailo, M D; Gerbing, R R et al. (2000) A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma. Cancer 88:2838-44

Showing the most recent 10 out of 16 publications